Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals
  4. Vaccines

Other Vaccines - Portugal

Portugal
  • In Portugal, the revenue in the Other Vaccines market is projected to reach US$106.80m in 2024.
  • It is expected to show an annual growth rate (CAGR 2024-2029) of 10.62%, resulting in a market volume of US$176.90m by 2029.
  • When comparing globally, United States is anticipated to generate the highest revenue of US$24.73bn in 2024.
  • Portugal is experiencing an increase in demand for other vaccines due to a growing awareness of the importance of preventive healthcare.

Definition:
This market covers all vaccines with the exception of COVID-19 vaccines. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi

In-Scope

  • Vaccines against infectious diseases
  • Prophylactic and theurapeutic vaccines
  • Flu vaccines

Out-Of-Scope

  • Sera and gammaglobulins
  • Antivirals
  • Antibiotics
  • COVID-19 vaccines
Pharmaceuticals: market data & analysis - Cover

Market Insights report

Pharmaceuticals: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Other Vaccines market in Portugal is showing signs of growth and development in recent years.

    Customer preferences:
    There is a growing awareness among Portuguese citizens about the importance of vaccination and the need to protect against a range of diseases. As a result, there has been an increase in demand for other vaccines beyond the traditional ones. Customers are looking for vaccines that can protect them from a range of illnesses, including those that are not covered by the national vaccination program.

    Trends in the market:
    The Other Vaccines market in Portugal has seen a shift towards preventive healthcare and wellness. This has led to an increase in demand for vaccines that can help prevent the onset of diseases. There has also been a growing trend towards personalized medicine, with customers looking for vaccines that are tailored to their specific needs. This has led to an increase in the development of new vaccines that target specific diseases or population groups.

    Local special circumstances:
    Portugal has a well-developed healthcare system that provides universal coverage to its citizens. The country has a high level of health literacy, which has contributed to the growing demand for other vaccines. Additionally, Portugal has a large elderly population, which is particularly vulnerable to a range of diseases. This has led to an increase in demand for vaccines that can protect against illnesses such as pneumonia and shingles.

    Underlying macroeconomic factors:
    The Portuguese economy has been growing steadily in recent years, which has led to an increase in disposable income. This has made it easier for customers to access healthcare services, including vaccines. Additionally, the government has been investing in the healthcare sector, which has led to an increase in the availability of vaccines. The country's strategic location has also made it an attractive destination for pharmaceutical companies looking to expand their operations in Europe. This has led to an increase in the development and availability of other vaccines in the market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Pharmaceuticals: market data & analysis - BackgroundPharmaceuticals: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.